- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
JCR Pharmaceuticals Co Ltd (4552)JCR Pharmaceuticals Co Ltd stock price live, this page displays TYO 4552 stock exchange data. View the 4552 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the JCR Pharmaceuticals Co Ltd real time stock price chart below.
What Is the JCR Pharmaceuticals Co Ltd Stock Price Today?
The JCR Pharmaceuticals Co Ltd stock price today is 720.0.
What Is the Stock Symbol for JCR Pharmaceuticals Co Ltd?
The stock symbol for JCR Pharmaceuticals Co Ltd is "4552."
What Stock Exchange Does JCR Pharmaceuticals Co Ltd Trade On?
JCR Pharmaceuticals Co Ltd is listed and trades on the Tokyo stock exchange.
Is JCR Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether JCR Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4552 quote. (ISIN: JP3701000006)
What Is the JCR Pharmaceuticals Co Ltd Stock Price Today?
The JCR Pharmaceuticals Co Ltd stock price today is 720.0.
What Is the Stock Symbol for JCR Pharmaceuticals Co Ltd?
The stock symbol for JCR Pharmaceuticals Co Ltd is "4552."
What Stock Exchange Does JCR Pharmaceuticals Co Ltd Trade On?
JCR Pharmaceuticals Co Ltd is listed and trades on the Tokyo stock exchange.
Is JCR Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether JCR Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4552 quote. (ISIN: JP3701000006)
Tokyo
Currency in JPY
720.0
+1.0(+0.14%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
710.0
729.0
52 wk Range
466.0
1,228.0
4552 Scorecard
Full Analysis
Prominent player in the Pharmaceuticals industry
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
710.0729.0
52 wk Range
466.01,228.0
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(2.78%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
Unlock(2.78%)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
Unlock4552 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Price Target
872.9
Upside
+21.2%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has maintained dividend payments for 32 consecutive years
JCR Pharmaceuticals Company Profile
JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells, imports, and exports medical devices and laboratory instruments; and purchases and sells medical and research equipment. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies; and a. joint research agreement with Modalis Therapeutics Corporation to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan.
Compare 4552 to Peers and Sector
Metrics to compare | 4552 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4552PeersSector | |
|---|---|---|---|---|
P/E Ratio | −200.7x | 12.4x | −0.6x | |
PEG Ratio | 1.90 | 0.04 | 0.00 | |
Price/Book | 1.5x | 1.0x | 2.6x | |
Price / LTM Sales | 2.5x | 1.4x | 3.2x | |
Upside (Analyst Target) | −6.9% | 12.0% | 44.6% | |
Fair Value Upside | Unlock | 17.0% | 7.3% | Unlock |
Analysts' Recommendations
2 Buy
5 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 872.9
(+21.23% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -3.5
Dividend Yield
2.78%
Industry Median 2.25%
Annualised payout
20
Paid unevenly
5-Years Growth
+18.66%
Growth Streak
FAQ
What Is the JCR Pharmaceuticals (4552) Stock Price Today?
The JCR Pharmaceuticals stock price today is 720.00.
What Stock Exchange Does JCR Pharmaceuticals Trade On?
JCR Pharmaceuticals is listed and trades on the Tokyo stock exchange.
What Is the Stock Symbol for JCR Pharmaceuticals?
The stock symbol for JCR Pharmaceuticals is "4552."
Does JCR Pharmaceuticals Pay Dividends? What’s The Current Dividend Yield?
The JCR Pharmaceuticals dividend yield is 2.78%.
What Is the JCR Pharmaceuticals Market Cap?
As of today, JCR Pharmaceuticals market cap is 87.71B.
What is JCR Pharmaceuticals Earnings Per Share?
The JCR Pharmaceuticals EPS is -3.50.
What Is the Next JCR Pharmaceuticals Earnings Date?
JCR Pharmaceuticals will release its next earnings report on 29 Jan 2025.
From a Technical Analysis Perspective, Is 4552 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.